ArticleFrontiers in endocrinology2025

Efficacy and safety of once-weekly semaglutide monotherapy in a young subject with Prader-Willi syndrome, obesity, and type 2 diabetes: a case report.

Elisa Dinoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.